(Q37321865)
Statements
1 reference
Bevacizumab and erlotinib: a promising new approach to the treatment of advanced NSCLC. (English)
1 reference
Roy S Herbst
1 reference
Alan Sandler
1 reference
8 November 2008
1 reference
1 reference
13
1 reference
11
1 reference
1166-1176
1 reference
Identifiers
1 reference
1 reference